Kimberly Gentile

2019

In 2019, Kimberly Gentile earned a total compensation of $2.7M as Senior Vice President, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd., a 4% decrease compared to previous year.

Compensation breakdown

Bonus$228,042
Option Awards$1,205,401
Salary$372,313
Stock Awards$861,000
Other$13,734
Total$2,680,490

Gentile received $1.2M in option awards, accounting for 45% of the total pay in 2019.

Gentile also received $228K in bonus, $372.3K in salary, $861K in stock awards and $13.7K in other compensation.

Rankings

In 2019, Kimberly Gentile's compensation ranked 4,555th out of 13,971 executives tracked by ExecPay. In other words, Gentile earned more than 67.4% of executives.

ClassificationRankingPercentile
All
4,555
out of 13,971
67th
Division
Manufacturing
1,702
out of 5,701
70th
Major group
Chemicals And Allied Products
595
out of 2,200
73rd
Industry group
Drugs
501
out of 1,886
73rd
Industry
Pharmaceutical Preparations
378
out of 1,398
73rd

Pay ratio

Kimberly Gentile's Pay$2,680,490
Median Employee's Pay$165,840
Pay Ratio

16

to 1

In 2019, the annual total compensation of Kimberly Gentile was $2,680,490.

The annual total compensation of the median employee at Biohaven Pharmaceutical Holding Co Ltd. was $165,840.

The ratio of Kimberly Gentile's pay to the pay of median employee was therefore 16 to one.

Source: SEC filing on March 20, 2020.

Gentile's colleagues

We found four more compensation records of executives who worked with Kimberly Gentile at Biohaven Pharmaceutical Holding Co Ltd. in 2019.

2019

Vlad Coric

Biohaven Pharmaceutical Holding Co Ltd.

Chief Executive Officer

2019

William Jones

Biohaven Pharmaceutical Holding Co Ltd.

Chief Commercial Officer of Migraine & Common Diseases

2019

James Engelhart

Biohaven Pharmaceutical Holding Co Ltd.

Chief Financial Officer

2019

Elyse Stock

Biohaven Pharmaceutical Holding Co Ltd.

Chief Medical Officer

News

You may also like